TABLE OF CONTENTS
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Impact on Demand
5.3.4. Impact on R&D
6. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT
6.1. Overview
6.2. Prefilled Needle-Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
6.3. Fillable Needle-Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
7. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE
7.1. Overview
7.2. Liquid-Based Needle Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
7.3 Powder-Based Needle Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
7.1. Projectile/Depot-Based Needle Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
8. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY
8.1. Overview
8.2. Jet-Based Needle-Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
8.3. Spring-Based Needle-Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
8.4. Micro Array Patch Injectors
Market Estimates & Forecast, by Region, 2022–2030
8.5. Others
Market Estimates & Forecast, by Region, 2022–2030
9. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY
9.1. Overview
9.2. Intra Dermal Injectors
Market Estimates & Forecast, by Region, 2022–2030
9.3. Intramuscular Injectors
Market Estimates & Forecast, by Region, 2022–2030
9.4. Subcutaneous Injectors
Market Estimates & Forecast, by Region, 2022–2030
10. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY
10.1. Overview
10.2. Disposable Needle-Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
10.3. Reusable Needle-Free Injectors
Market Estimates & Forecast, by Region, 2022–2030
11. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION
11.1. Overview
11.2. Vaccine Delivery
Market Estimates & Forecast, by Region, 2022–2030
11.3. Insulin Delivery
Market Estimates & Forecast, by Region, 2022–2030
11.4. Pain Management
Market Estimates & Forecast, by Region, 2022–2030
11.5. Others
Market Estimates & Forecast, by Region, 2022–2030
12. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER
12.1. Overview
12.2. Hospitals and Clinics
Market Estimates & Forecast, by Region, 2022–2030
12.3. Homecare Settings
Market Estimates & Forecast, by Region, 2022–2030
12.4. Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2022–2030
12.5. Others
Market Estimates & Forecast, by Region, 2022–2030
13. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION
13.1. Overview
13.2. North America
13.2.1. US
13.2.2. Canada
13.3. Europe
13.3.1. Germany
13.3.2. France
13.3.3. Italy
13.3.4. Spain
13.3.5. UK
13.3.6. Rest of Europe
13.4. Asia-Pacific
13.4.1. Japan
13.4.2. China
13.4.3. India
13.4.4. Australia
13.4.5. South Korea
13.4.6. Rest of Asia-Pacific
13.5. Rest of the World
13.5.1. Middle East & Africa
13.5.2. Latin America
14. COMPANY LANDSCAPE
14.1. Overview
14.2. Competitive Analysis
14.3. Market Share Analysis
14.4. Major Growth Strategy in the Global Needle-Free Injection System Market
14.5. Competitive Benchmarking
14.6. Leading Players in Terms of Number of Developments in the Global Needle-Free Injection System Market
14.7. Key Developments and Growth Strategies
14.7.1. New Product Launch/Service Deployment
14.7.2. Merger & Acquisitions
14.7.3. Joint Ventures
14.8. Major Players Financial
14.8.1. Sales & Operating Income, 2021
14.8.2. Major Players R&D Expenditure, 2021
15. COMPANY PROFILES
15.1. Medical International Technology (MIT)
15.1.1. Company Overview
15.1.2. Products Offered
15.1.3. Financial Overview
15.1.4. Key Developments
15.1.5. SWOT Analysis
15.1.6. Key Strategies
15.2. PharmaJet.
15.2.1. Company Overview
15.2.2. Products Offered
15.2.3. Financial Overview
15.2.4. Key Developments
15.2.5. SWOT Analysis
15.2.6. Key Strategies
15.3. Antares Pharma.
15.3.1. Company Overview
15.3.2. Products Offered
15.3.3. Financial Overview
15.3.4. Key Developments
15.3.5. SWOT Analysis
15.3.6. Key Strategies
15.4. Endo International
15.4.1. Company Overview
15.4.2. Products Offered
15.4.3. Financial Overview
15.4.4. Key Developments
15.4.5. SWOT Analysis
15.4.6. Key Strategies
15.5. Ferring B.V.
15.5.1. Company Overview
15.5.2. Products Offered
15.5.3. Financial Overview
15.5.4. Key Developments
15.5.5. SWOT Analysis
15.5.6. Key Strategies
15.6. Bioject Medical Technologies
15.6.1. Company Overview
15.6.2. Products Offered
15.6.3. Financial Overview
15.6.4. Key Developments
15.6.5. SWOT Analysis
15.6.6. Key Strategies
15.7. NuGen Medical Devices
15.7.1. Company Overview
15.7.2. Products Offered
15.7.3. Financial Overview
15.7.4. Key Developments
15.7.5. SWOT Analysis
15.7.6. Key Strategies
15.8. Portal Instruments
15.8.1. Company Overview
15.8.2. Products Offered
15.8.3. Financial Overview
15.8.4. Key Developments
15.8.5. SWOT Analysis
15.8.6. Key Strategies
15.9. Enesi Pharma Limited
15.9.1. Company Overview
15.9.2. Products Offered
15.9.3. Financial Overview
15.9.4. Key Developments
15.9.5. SWOT Analysis
15.9.6. Key Strategies
15.10. Crossject
15.10.1. Company Overview
15.10.2. Products Offered
15.10.3. Financial Overview
15.10.4. Key Developments
15.10.5. SWOT Analysis
15.10.6. Key Strategies
16. APPENDIX
16.1. References
16.2. Related Reports 
LIST OF TABLES
TABLE 1 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SYNOPSIS, 2022–2030
TABLE 2 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET ESTIMATES & FORECAST, 2022–2030 (USD MILLION)
TABLE 3 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 4 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 5 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 6 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 7 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 8 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 9 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 10 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 11 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 12 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 13 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 14 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 15 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 16 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 17 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 18 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 19 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 20 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 21 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 22 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 23 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 24 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 25 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 26 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 27 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 28 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 29 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 30 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 31 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 32 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 33 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 34 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 35 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 36 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 37 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 38 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 39 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 40 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 41 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 42 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 43 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 44 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 45 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 46 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 47 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 48 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 49 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 50 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 51 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 52 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 53 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 54 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 55 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 56 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 57 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 58 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 59 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 60 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 61 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 62 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 63 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 64 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 65 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 66 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 67 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 68 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 69 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 70 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 71 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 72 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 73 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 74 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 75 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 76 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 77 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 78 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 79 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 80 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 84 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 85 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 86 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 87 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 88 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 89 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 90 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 91 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 92 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 93 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 94 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 95 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 96 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 97 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 98 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 99 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 100 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 101 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 102 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 103 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 104 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 105 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 106 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 107 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 108 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 109 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 110 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 111 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 112 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 113 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 114 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 115 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 116 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 117 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 118 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 119 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 120 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 121 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 122 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 123 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 124 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 125 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 126 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 127 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 128 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 129 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 130 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 131 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 132 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 133 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 134 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 135 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 136 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 137 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 138 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 139 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 140 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 141 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 142 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 143 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 144 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 145 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 146 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 147 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022–2030 (USD MILLION)
TABLE 148 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 149 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
TABLE 150 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 151 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 152 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION)
TABLE 153 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022–2030 (USD MILLION)
TABLE 154 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, USABILITY, 2022–2030 (USD MILLION)
TABLE 155 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
TABLE 156 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET
FIGURE 4 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY PRODUCT, 2021
FIGURE 5 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY TYPE, 2021
FIGURE 6 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY TECHNOLOGY, 2021
FIGURE 7 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY SITE OF DELIVERY, 2021
FIGURE 8 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY USABILITY, 2021
FIGURE 9 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY APPLICATION, 2021
FIGURE 10 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY END USERS, 2021
FIGURE 11 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021
FIGURE 12 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021 (%)
FIGURE 13 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021
FIGURE 14 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021
FIGURE 15 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE, BY REGION, 2021 (%)
FIGURE 16 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET: COMPANY SHARE(%) ANALYSIS, 2021 (%)
FIGURE 17 MEDICAL INTERNATIONAL TECHNOLOGY (MIT): KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 MEDICAL INTERNATIONAL TECHNOLOGY (MIT): SWOT ANALYSIS
FIGURE 19 PHARMAJET.: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 PHARMAJET.: SWOT ANALYSIS
FIGURE 21 THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 23 ENDO INTERNATIONAL.: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ENDO INTERNATIONAL.: SWOT ANALYSIS
FIGURE 25 FERRING B.V.: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 FERRING B.V.: SWOT ANALYSIS
FIGURE 27 BIOJECT MEDICAL TECHNOLOGIES: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 BIOJECT MEDICAL TECHNOLOGIES: SWOT ANALYSIS
FIGURE 29 NUGEN MEDICAL DEVICES: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 NUGEN MEDICAL DEVICES: SWOT ANALYSIS
FIGURE 31 PORTAL INSTRUMENTS: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 PORTAL INSTRUMENTS: KEY SWOT ANALYSIS
FIGURE 33 ENESI PHARMA LIMITED: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ENESI PHARMA LIMITED: SWOT ANALYSIS
FIGURE 35 CROSSJECT: KEY FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 CROSSJECT: SWOT ANALYSIS